While medical advancements and drug therapy innovations have been life-changing for patients and plan members, they also come with increasing costs, said Victoria Shaw, drug benefits manager at Alberta Blue Cross, speaking at Benefits Canada’s 2019 Calgary Drug Trends Summit on Oct. 24. Between 2011 to 2017, the number of high-cost drugs doubled. From 2016 to 2017, in […]
When it comes to health-care spending in Canada, there isn’t a lot of variance between provinces, according to Joe Farago, executive director of private payers and investment at Innovative Medicines Canada. In a session at Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24, he said prescription drugs’ percentage of the total health-care budget has been fairly consistent, at 15 […]
As the prevalence of diabetes continues to rise, so do the increases in cost, according to Adam Hotchkiss, medical science liaison at Novo Nordisk Canada, during Benefits Canada‘s 2019 Halifax Benefits Summit on Sept. 24. “In 2010, $11.7 billion was spent in Canada on the treatment of diabetes as well as its complications,” he said. “This is […]
When an employee has a health issue requiring expensive treatment, the associated high-cost claims can be significant for their benefits plan sponsor. But it’s impossible to predict when a large claim will arise, so stop-loss insurance, which takes the claim off the employer’s shoulders, is one option to help protect against these unexpected costs. As […]
Quebec’s universal pharmacare program offers better drug coverage and quicker approval for new drugs coming to market than the rest of Canada, according to a new study by the Fraser Institute. Looking at drugs approved by Health Canada between 2008 and 2017, the report found Quebec went on to cover 33.4 per cent of them, […]
Plan sponsors can expect to see a three to five per cent increase in prescription drug claims in 2019, according to Buck’s annual Canadian health-care trend survey. However, the survey noted, since insurance providers also add a market inflation factor, the projected increase is actually 10.99 per cent, down from 12.45 per cent in 2018. Based […]
Plan sponsors are increasingly adopting plan design tools to manage their drug plan costs, according to Telus Health’s annual drug trends report. It found private plan drug costs have grown 0.3 per cent per year on average for the past 10 years, made up of an average 2.1 per cent annual decrease in the cost […]
Benefits Canada is extending the deadline for entering the 2019 Workplace Benefits Awards to Monday, July 15. The annual awards, which will be held in Toronto on Oct. 17, recognize employers and plan sponsors that are leading the industry in their approaches to supporting the mental, physical and financial well-being of their employees. Enter the 2019 Workplace […]
Plan sponsors and plan members are unaware of the key differences between private and public drug plans, according to the 2019 Sanofi Canada health-care survey. Both employer and employee respondents said they believe private and public prescription drug plans cover close to the same amount of medications. Plan members estimated about 6,600 drugs are covered under private […]
On May 24, the 2019 Vancouver Benefits Summit focused on how employers can make their organization its healthiest by starting with their benefits plans. Here’s what you missed! Panel: Should drug coverage for certain conditions still be optional? In many workplace drug plans, medications that treat certain conditions remain in the optional life category, but is […]